Importer of Controlled Substances Registration
Federal Register, Volume 83 Issue 70 (Wednesday, April 11, 2018)
Federal Register Volume 83, Number 70 (Wednesday, April 11, 2018)
Notices
Page 15633
From the Federal Register Online via the Government Publishing Office www.gpo.gov
FR Doc No: 2018-07444
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Docket No. DEA-392
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Sharp (Bethlehem), LLC................ 83 FR 539..................... January 4, 2018.
Catalent Pharma Solutions, LLC........ 83 FR 2215.................... January 16, 2018.
Janssen Pharmaceuticals, Inc.......... 83 FR 2214.................... January 16, 2018.
Mylan Pharmaceuticals, Inc............ 83 FR 5809.................... February 9, 2018.
Meridian Medical Technologies, Inc.... 83 FR 5810.................... February 9, 2018.
Noramco, Inc.......................... 83 FR 5810.................... February 9, 2018.
Johnson Matthey, Inc.................. 83 FR 5811.................... February 9, 2018.
Mylan Technologies, Inc............... 83 FR 5811.................... February 9, 2018.
Mylan Pharmaceuticals, Inc............ 83 FR 8107.................... February 23, 2018.
----------------------------------------------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.
Dated: April 4, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
FR Doc. 2018-07444 Filed 4-10-18; 8:45 am
BILLING CODE 4410-09-P
